世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033246

世界のヒトインスリン製剤およびデリバリーデバイスの市場規模調査:薬剤タイプ別、デバイスタイプ別、地域別の予測(2022年〜2028年)

Bizwit Research & Consulting LLP

Global Human Insulin Drugs and Delivery Devices Market Size study, by Drug Type (Basal or Long-acting Insulins, Bolus or Fast-acting Insulins, Traditional Human Insulins, Combination Insulins, and Biosimilar Insulins), by Device Type (Insulin Pens, Insulin Pumps, Insulin Syringes, and Jet Injectors) and Regional Forecasts 2022-2028

発刊日 2022/09/15

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000033246

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界のヒトインスリン製剤およびデリバリーデバイス市場は、2021年に約403億米ドルと評価され、予測期間の2022年から2028年には3%を超える健全な成長率で成長すると予測されています。タンパク質ホルモンであるインスリンは、体内で十分なインスリンを製造できない人が、高い血糖値をコントロールするのに役立ちます。脂肪組織や筋肉でのブドウ糖の取り込みを促進することで、インスリンは血糖値を下げます。これは、臀部、腹部、腕の裏側、または脚に注入することができます。さらに、インスリンは糖尿病の管理を助けるだけでなく、糖尿病性ケトアシドーシスや高スモル性高血糖など、その直接的な結果の治療にも使われます。市場の成長は、糖尿病患者数の増加やHIアナログの市場需要の高まりなどの主要因によってもたらされます。英連邦基金の調査によると、保険に加入していない糖尿病患者のアメリカ人は、メディケイド(Medicaid)や民間保険に加入している人に比べて、より古くて安価な(そして効果の低い)インスリン製剤を使用する傾向が強いとされています。保険未加入者の60%から80%がインスリンの定価全額を支払っているのに対し、民間保険加入者の9%、メディケイド受給者の3%は定価全額を支払っています。さらに、主要なHI Drugsの特許が切れることが予想されるため、全世界で市場機会が拡大すると考えられます。しかし、製品承認のための厳しい規制要件が、2022年から2028年の予測期間における市場の成長を阻害しています。

ヒトインスリン製剤およびデリバリーデバイスの世界市場調査において考慮した主要地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の世界です。北アメリカは、糖尿病患者の症例数が多く、増加傾向にあることから、市場全体のシェアをリードしています。しかし、アジア太平洋地域は、人々のライフスタイルの変化や不健康な食習慣により、最も急速に成長する地域と予想されます。

主要企業

  • Novo Nordisk A/S
  • Insulet
  • Eli Lilly
  • Exir
  • Biocon
  • Becton Dickinson
  • Medtronic
  • Ypsomed
  • Julphar
  • Sanofi Aventis

この調査の目的は、近年の様々なセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。

市場セグメント・サブセグメント

  • 薬剤タイプ別
    ➣ 基礎型または長時間作用型インスリン
    ➣ ボーラスまたは速効性インスリン
    ➣ 従来のヒト型インスリン
    ➣ 複合型インスリン
    ➣ バイオシミラーインスリン
  • デバイスタイプ別
    ➣ インスリンペン
    ➣ インスリンポンプ
    ➣ インスリン注射器
    ➣ ジェットインジェクター
  • 地域別
    ➣ 北アメリカ
      ◇ アメリカ
      ◇ カナダ
    ➣ ヨーロッパ
      ◇ イギリス
      ◇ ドイツ
      ◇ フランス
      ◇ スペイン
      ◇ イタリア
      ◇ その他のヨーロッパ
    ➣ アジア太平洋地域
      ◇ 中国
      ◇ インド
      ◇ 日本
      ◇ オーストラリア
      ◇ 韓国
      ◇ その他のAPAC
    ➣ ラテンアメリカ
      ◇ ブラジル
      ◇ メキシコ
    ➣ 世界のその他の地域

調査対象の年

  • 実績データ - 2018年、2019年、2020年
  • 基準年 - 2021年
  • 予測期間 - 2022年から2028年

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Human Insulin Drugs and Delivery Devices Market, by region, 2020-2028 (USD Billion)
1.2.2. Human Insulin Drugs and Delivery Devices Market, by Drug Type, 2020-2028 (USD Billion)
1.2.3. Human Insulin Drugs and Delivery Devices Market, by Device Type, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Human Insulin Drugs and Delivery Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Human Insulin Drugs and Delivery Devices Market Dynamics
3.1. Human Insulin Drugs and Delivery Devices Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growth in the Number of Diabetic Patients
3.1.1.2. Rising Market Demand for HI Analogs
3.1.2. Market Challenges
3.1.2.1. Stringent Regulatory Requirements for Product Approval
3.1.3. Market Opportunities
3.1.3.1. Expected Patent Expiry of Key HI Drugs
3.1.3.2. Emerging Markets

Chapter 4. Global Human Insulin Drugs and Delivery Devices Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Human Insulin Drugs and Delivery Devices Market, by Drug Type
6.1. Market Snapshot
6.2. Global Human Insulin Drugs and Delivery Devices Market by Drug Type, Performance - Potential Analysis
6.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Drug Type, 2018-2028 (USD Billion)
6.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
6.4.1. Basal or Long-acting Insulins
6.4.2. Bolus or Fast-acting Insulins
6.4.3. Traditional Human Insulins
6.4.4. Combination Insulins
6.4.5. Biosimilar Insulins

Chapter 7. Global Human Insulin Drugs and Delivery Devices Market, by Device Type
7.1. Market Snapshot
7.2. Global Human Insulin Drugs and Delivery Devices Market by Device Type, Performance - Potential Analysis
7.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Device Type, 2018-2028 (USD Billion)
7.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
7.4.1. Insulin Pens
7.4.2. Insulin Pumps
7.4.3. Insulin Syringes
7.4.4. Jet Injectors

Chapter 8. Global Human Insulin Drugs and Delivery Devices Market, Regional Analysis
8.1. Human Insulin Drugs and Delivery Devices Market, Regional Market Snapshot
8.2. North America Human Insulin Drugs and Delivery Devices Market
8.2.1. U.S. Human Insulin Drugs and Delivery Devices Market
8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2028
8.2.1.2. Device Type breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Human Insulin Drugs and Delivery Devices Market
8.3. Europe Human Insulin Drugs and Delivery Devices Market Snapshot
8.3.1. U.K. Human Insulin Drugs and Delivery Devices Market
8.3.2. Germany Human Insulin Drugs and Delivery Devices Market
8.3.3. France Human Insulin Drugs and Delivery Devices Market
8.3.4. Spain Human Insulin Drugs and Delivery Devices Market
8.3.5. Italy Human Insulin Drugs and Delivery Devices Market
8.3.6. Rest of Europe Human Insulin Drugs and Delivery Devices Market
8.4. Asia-Pacific Human Insulin Drugs and Delivery Devices Market Snapshot
8.4.1. China Human Insulin Drugs and Delivery Devices Market
8.4.2. India Human Insulin Drugs and Delivery Devices Market
8.4.3. Japan Human Insulin Drugs and Delivery Devices Market
8.4.4. Australia Human Insulin Drugs and Delivery Devices Market
8.4.5. South Korea Human Insulin Drugs and Delivery Devices Market
8.4.6. Rest of Asia Pacific Human Insulin Drugs and Delivery Devices Market
8.5. Latin America Human Insulin Drugs and Delivery Devices Market Snapshot
8.5.1. Brazil Human Insulin Drugs and Delivery Devices Market
8.5.2. Mexico Human Insulin Drugs and Delivery Devices Market
8.6. Rest of The World Human Insulin Drugs and Delivery Devices Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Sanofi Aventis
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Novo Nordisk A/S
9.2.3. Insulet
9.2.4. Eli Lilly
9.2.5. Exir
9.2.6. Biocon
9.2.7. Becton Dickinson
9.2.8. Medtronic
9.2.9. Ypsomed
9.2.10. Julphar

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Human Insulin Drugs and Delivery Devices Market, report scope
TABLE 2. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Drug Type 2018-2028 (USD Billion)
TABLE 4. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Device Type 2018-2028 (USD Billion)
TABLE 5. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 6. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 17. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 19. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 22. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 25. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 28. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 31. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 34. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 37. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 40. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 43. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 46. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 49. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 52. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Human Insulin Drugs and Delivery Devices Market
TABLE 55. List of primary sources, used in the study of global Human Insulin Drugs and Delivery Devices Market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

LIST OF FIGURES
FIG 1. Global Human Insulin Drugs and Delivery Devices Market, research methodology
FIG 2. Global Human Insulin Drugs and Delivery Devices Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Human Insulin Drugs and Delivery Devices Market, key trends 2021
FIG 5. Global Human Insulin Drugs and Delivery Devices Market, growth prospects 2022-2028
FIG 6. Global Human Insulin Drugs and Delivery Devices Market, porters 5 force model
FIG 7. Global Human Insulin Drugs and Delivery Devices Market, pest analysis
FIG 8. Global Human Insulin Drugs and Delivery Devices Market, value chain analysis
FIG 9. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Human Insulin Drugs and Delivery Devices Market, regional snapshot 2018 & 2028
FIG 15. North America Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
FIG 16. Europe Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
FIG 19. Global Human Insulin Drugs and Delivery Devices Market, company market share analysis (2021)

この商品のレポートナンバー

0000033246

TOP